Summary
This Notice of Funding Opportunity (NOFO) invites applications that propose to use mouse models to conduct rigorous preclinical testing of drugs or drug combinations currently used for other conditions, as well as investigational drugs at various stages of clinical development, predicted to be efficacious in AD/ADRD. This initiative will also support preclinical testing of repurposable or investigational drug candidates in combination with non-pharmacologic interventions leading to robust translational outcomes. The central goal is to establish robust proof of concept that will enable rational drug repurposing and combination therapy development for the treatment and prevention of AD/ADRD.
Eligibility
- Public and State Institutions of Higher Education
- Nonprofits Non Higher Education Without 501c3
- Private Institutions of Higher Education
- State Governments
- Other
- Independent School Districts
- For Profit Organizations Other Than Small Businesses
- County Governments
- Public and Indian Housing Authorities
- Small Businesses
- Special District Governments
- Native American Tribal Governments Federally Recognized
- Nonprofits Having A 501(c)(3) Status With the Irs Other Than Institutions of Higher Education
- Native American Tribal Organizations Other Than Federally Recognized Tribal Governments
- City Or Township Governments
Funding categories
- Health
Official source and attribution
This directory republishes federal opportunity information sourced from Simpler.Grants.gov and Grants.gov. Local Business Ranks is not affiliated with or endorsed by the federal government. Always rely on the official opportunity record for application requirements and changes.
Open the official federal record